Flashcards in Preventive Medecine Deck (66):
1
screenning test for pancreatic cancer
no test for that
2
why use ca 19-9
evaluation of the response to treatment
3
recommended vaccine in hiv(2)
the same guideline as normal individual
exception for live attenuated vaccine
4
When should be given Tetanos diphteria
q 10 ans
5
CAT in patient more than 65 ans who has never received tetanus toxoid
one dose of Tdap before receiving any booster
6
quid of Tdap(2)
tetanos
acellular petussis
7
smoking cessation(3)
bupropion
counselling
nicotine replacement
8
quid of bupropion(2)
antidepressant
approved by FDA
9
other drug used in smoking cessation and action.(2)
varenicline
partial agonist of nicotinic acetylcholine receptor
10
patient with anti HBS-antibody positive has AES in patient positive for Hep B CAT?
do nothing
11
patient with with unknown statut has AES in patient positive for Hep B CAT?
Immune globulin
vaccination series for Hep B
12
CAT in patient diabetic 40-75 ans with ten year cardiovascular risk
lifestyle modification
moderate statin use
13
when to begin prostate screening(3)
controversy
some say 40
some say case by case approach
14
screening of prostate cancer(2)
Psa
digital exam
15
recommendation for tetanos and diphteria prevention
starting after 18
TD q 10 ans
or for all ages Tdap at single dose
16
indication of pneumococcal vaccine in
chronic lung disease
chronic CV disease
diabetes mellitus
chronic liver disease
immunocpmpromised patient
functional or anatomic asplenia
alcoholism
cigarette
cochlear inplant
CSF leak
17
quid of chronic lung disease(3)
asthme
bronchite chronique
emphysema
18
cause of functionnal asplenia(4)
sickle cell disease
hemoglobinopathy
splenectomy
acquired asplenism
19
people who can receive intranasal influenza
healthy individual
20
people who cant receive intranasal influenza
what should be given
immunocompromised patient
intramuscular influenza vaccine
21
way to prevent decubitus ulcer(2)
change position q 2h
pressure reducing devices
22
patient at risk for decubitus ulcer(3)
immobility
poor nutrition
sensory impairment
23
quid of pressure reducing devices
air and foam mattress
24
when to screen breast cancer and when to start
q 2 ans
starting 50
25
when generally breast cancer is no more important
after 75
26
when to screen cervical cancer and when start(2)
q 3 ans
21 ans
27
frequency of screening for cervical cancer in 30-65 ans
q 5 ans
par smear et serology HPV
28
when to screen cervical cancer in immunocompromised patient(hiv,tranplanted or immunosuppresive drug)and frequency(2)
at the onset of sexual activity
annually but twice in the first year
29
screening for colon cancer in patient with parent killed by the ca
begin ten years earlier
30
screening for colon cancer in patient in general and frequency(2)
50 ans
q 10 ans
31
way of screening colon cancer(5)
fecal occult blood in feces
colonoscopy
Flexible sigmoidoscopy
FOBT plus flexible sigmoidoscopy
double contrast bayum enema
32
patient with cd4 less than 200 what vaccines should not be done to this patient
MMR
varicella
zoster
intranasal influenza
33
dose of Hep A vaccine in HIV patient or in general(2)
2 doses
the second a 6 mois de la premiere dose
34
dose of hep B in HIV or in general situation
3 doses
o month,1 month,4 month
35
frequency of Hi flu
one dose in infancy
36
best rx for claudication
exercice program
37
what should receive any patient with atherosclerotic risk(2)
(PAD)
statin
aspirin
38
criteria to scren abdominal aneurism
smoker
> 65
39
frequency of screening for abdominal aneurism
one time
40
way of screening abdominal aneurism
U/S
41
number of dose of PPSV(pneumonia vaccine)(2)
1 or 2(repeat in 5 yars)
more than 65 years one dose
42
patient going to egypt important vaccine to be given(or north africa or any developing country)(4)
-Hep A
Hep B
typhoide
Polyo
43
CAT in patient with atherosclerotic risk disease 75 ans
high intensity statin
44
CAT in patient with atherosclerotic risk disease > 75 ans
moderate intensity statin
45
quid of atherosclerotic disease(3)
stroke
pad
CAD
46
CAT in LDL >/190 mg/dl
high intensity statin
47
diabetic entre 40-75 ans patient with 10 year atherosclerotic cardiovascular risk >/ 7,5
high intensity statin
48
diabetic entre 40-75 ans patient with 10 year atherosclerotic cardiovascular risk
moderate intensity statin
49
patient with 10 year atherosclerotic cardiovascular risk >/ 7,5
moderate to high intensity statin
50
prevention of influenza in immunocompromised patient
IM influenza vaccine
51
mechanism of action of pneumococcal pneumoniae prevention using the polyvalent pneumococcal vaccine
T-cell independent B cell response
52
why polyvalent pneumococal vaccine cannot activate T cell(2)
because it's just polysaccharides of the 23 most prevalent types of pneumococcus
polysaccharides cannot be presented to t cell
53
quid of heptavalent pneumococcus vaccine(2)
use in children
t cell dependent b cell response
54
screnning test in any sexually active women
chlamydia trachomatis
55
risk for bladder cancer(2)
smoking
industrial chemical
56
screening of bladder cancer
no screening
57
when to screen patient for osteoporosis
starting after 65 ans
58
quid of osteoporosis
bone density > 2,5 of standard deviation or
T
59
quid of osteopenia
T entre -1 et -2,5
60
the most important risk factor for osteoporosis in the US
post menopause
61
risk factor for osteoporosis(6)
poor intake of VitD and calcium
smoking
common steroid use
lack of weight bearing exercice
low body mass index
62
secondary cause of osteoporosis(11)
premature menopause
hypogonadism
malabsorption disease
IBD
rhumatoid arthritis
cushing syndrome
hyperthyroidism
hyperparathyroidism
vit D deficiency
chronic liver disese
renal disease
63
screening test for hyperlipidemia in men when to start and frequency(2)
> 35 ans
lipid panel q 5 ans
64
when mamo is no longer important in screening breast ca
after 75 ans
65
high intensity statin(2)
atorvastatin 40-80
rosuvastatin 20-40 mg
66